FDA Approves New Self-Collection Option for HPV Testing
"HPV self-collection offers an accessible screening option" and "will improve access to testing by providing women the option to privately collect their own sample," Roche said in a press release. The company added that this could help reduce a barrier to screening and contribute to the WHO's goal of eliminating cervical cancer by 2030.